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“Omnia mutantur, nihil interit” (Everything changes, nothing
perishes)
–Ovid, Metamorphoses, AD 8
The twenty-first century started with the Big Bang—the first ever
sequencing of the human genome in 2000/2003 (Lander et al.,
2001; Venter, 2003), and since then our scientific Universe started
to expand with the speed of light. This year (2012) the Supernova
exploded—the Encode project, a series of thirty papers, trashed
the “junk DNA” concept. The project indicates that the vast
majority (99%) of the human genome, although non-coding, is
not “junk” but is biologically active and essential to maintain
fundamental processes in a cell (Bernstein et al., 2012). One of
the earlier stellar breakthroughs was the discovery of microRNA,
a short RNA species crucial for regulation of gene expression
(Lee et al., 1993). With discoveries like these, it becomes more
and more obvious that our biological Universe is much more
complex and dynamic than we have ever imagined. It is very
probable that many biological rules and regulations still await dis-
covery. This is particularly important for our understanding of
the mechanisms underlying the development of chronic diseases,
like addiction. Addiction is a persistent, neurobiological dis-
ease affecting primarily the brain’s reward system, which consists
of a circuitry of several interconnecting brain regions, includ-
ing the prefrontal cortex, nucleus accumbens, ventral tegmental
area, amygdala, paraventricular nucleus, and others (Koob and
Le Moal, 2001). The reward system is one of the most important
physiological features of the brain. We use it constantly, uncon-
sciously, to make countless decisions essential to complete simple
and complex tasks, by performing risk/benefit ratio analyses. This
powerful motivator drives human and animal behavior, allows an
individual to thrive and ultimately, for a species to propagate.
Some drugs target the reward system and can drastically
change the behavior of individuals vulnerable to addiction, which
is characterized as the refocusing of all activities on one goal—
the continued intake of the drug. The drug’s effect on the CNS
is so powerful that the individual will continue to use it despite
any associated adverse consequences. Neurobiological models of
addiction try to explain how chronic or frequent exposure to
addictive drugs hijacks the elements of the brain reward circuitry
and causes transition from voluntary drug-taking to habitual and
compulsive drug-seeking (Hyman and Malenka, 2001). During
this transition, neuronal adaptations occur, which perpetuate
and intensify the disease. Escalating drug intake due to tolerance
causes incessant transition of the allostatic set-point, which fails
to maintain system stability. Usually, drug addiction and alco-
hol addiction are described separately, but at the biological level
both addictions have common core changes in the reward system
through similar neuronal adaptations. However, in either type of
addiction, many molecular underpinnings are still unknown.
Recently, several papers described the involvement of dif-
ferent non-coding RNAs, primarily microRNA, in unraveling
novel molecular mechanisms of this debilitating disease. We put
together this Special Issue of Frontiers in Genetics to provide
our readers with a comprehensive overview of current research
on non-coding RNA in both drug and alcohol addiction. We
invited leaders in this dynamic new field to write a series of
reviews, and other prominent scientists to share their views of
this subject through a series of editorials. This special issue is
divided into five chapters: alcohol, nicotine, cocaine, morphine,
and bioinformatics.
Alcohol is a simple product of yeast fermentation, and is fairly
easy to obtain. People have been using alcohol probably from the
beginning of recorded history. Alcohol addiction (alcoholism) is
the oldest and most widespread type of addiction. In this special
issue, Nunez and Mayfield (2012) describe microRNA signatures
in the brains of alcoholics and the process of microRNA modula-
tion of epigenetic nuclear mechanisms. Miranda (2012) discusses
teratological consequences of microRNA disregulation by alco-
hol during fetal development. The editorial by Reilly (2012)
explains how studying microRNA can provide new perspec-
tives and treatments of alcoholism and Fetal Alcohol Spectrum
Disorder (FASD).
Nicotine is primarily inhaled during the smoking of dried
tobacco leaves (Nicotiana tabacum), but also can be consumed in
other forms. Nicotine addiction has spread quickly around the
world in the post-Columbian era, becoming a major, present-
day health issue in many countries. According to Maccani and
Knopik (2012), detrimental effects of nicotine start very early—
in utero. They describe in their review how maternal cigarette
smoking during pregnancy alters expression of selected microR-
NAs in placenta. They also discuss the effect of cigarette smoking
onmicroRNA and long non-coding RNA (lncRNA) expression in
the epithelium of airways, which is important in the pathogenesis
of cancer. Their review indicates that environmentally regulated
epigenetic changes affect health throughout the course of one’s
life, while an editorial by Ehringer (2012) describes the pres-
ence of “critical periods” during which the environmental effect
is particularly strong.
Morphine is the most abundant alkaloid found in opium
(opiate), a product of the poppy fruit (Papaver somniferum).
Morphine has been used for centuries to treat pain. However,
morphine and related products have very potent addictive prop-
erties. Currently, addiction to morphine and related drugs is
rising, mainly in affluent countries. Several microRNAs have been
shown to be important in morphine actions. In this Special Issue,
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Rodriquez (2012) summarizes the regulation of miR-133b by
morphine and its possible involvement in morphine addiction
and cancer. He andWang (2012) describe the role of let-7, the first
identified humanmicroRNA, in regulation ofmorphine receptors
important during the development of opioid tolerance. Zheng
et al. (2012) center their review onmicroRNA-23b and -190. They
also propose that a non-coding RNA relevant to opioid addiction
can belong to one of two groups: (1) directly regulated by opioids,
or (2) not-regulated by opioids but controlling pathways lead-
ing to addiction. Wood and Lipovich (2012), in their editorial,
stress the importance of a systematical examination of the evo-
lutionary conservation of microRNAs and their targets in opioid
research.
Cocaine is an alkaloid obtained from the leaves of the coca
plant (Erythroxylum family). Chewing raw coca leaves seems to be
non-addictive, probably because of a very small content (<1%)
of cocaine in the leaves. Coca in this form is a mild stimulant and
analgesic and also a source of nutrients. However, purified cocaine
has strong addictive properties. Currently, cocaine addiction is
on a rise, and cocaine addicts can be found in many corners of
the world. Wu (2012) in his editorial emphasizes advantages of a
novel approach to study cocaine addiction using next-generation
sequencing. The powerful results of this great methodology are
appreciated by the review by Eipper-Mains et al. (2012). The
review by Bali and Kenny (2012) describes their elegant studies
implicating the regulation of CREB, MeCP2, and BDNF path-
ways by specific microRNAs (miR-132 and -212) in the behavioral
response to cocaine.
We added a special chapter on bioinformatics because wet
lab experimental approaches to microRNA research are initi-
ated or complemented by bioinformatical experiments. There are
several challenges to ensure synergism between next-generation
techniques and bioinformatic analyses as emphasized in the
editorial by Liu et al. (2012). The review by Mu and Zhang
(2012) provides a comprehensive comparison of several bioin-
formatical resources important in addiction research. This spe-
cial chapter also contains an article by Sartor et al. (2012),
which draws our attention not only to the importance of
microRNA but also to its “longer” brother—the lncRNA, in
persistent neuronal maladaptation associated with addictive
behaviors.
Research trying to understand involvement of various types
of non-coding RNA in the development of addictions is at its
early stages. Not all of the addictive substances have been yet
screened. Moreover, an addiction can occur not only to exoge-
nous chemicals but also to other cues like gambling, food, internet
etc. Future research should look into the misregulation of gene
expression by non-coding RNA in all the different types of addic-
tion (Pietrzykowski, 2010). Nevertheless, the work discussed in
this Special Issue has already left a strong legacy: there is no
doubt that non-coding RNAs play absolutely essential roles in
processes controlled by addictive drugs. Thus, to truly understand
addictions, one must study non-coding RNA.
Research in non-coding RNA will probably increase expo-
nentially, because we are now at a really advantageous situation
in biological history—an intersection of several revolutions. The
technical revolution provides the increasing ability to perform
a deep, accurate, and fast sequencing of entire genomes. The
bioinformatical revolution provides more and more sophisticated
tools to analyze gigabytes of information delivered by sequenc-
ing. The genome structure revolution has started to disentangle
intertwined genomic three-dimensional networks of interactions
between genes and gene regulatory regions. Inevitably, we have
started to experience the conceptual revolution: we realize that
the regulation of gene expression is a multilevel interactive pro-
cess, much more complex than we initially thought, and that
messenger RNA can regulate each other via miRNA sequestering
as proposed in the ceRNA (complementary endogenous) theory
(Salmena et al., 2011), and that circulating exosomes can contain
gene regulatory material, like microRNA and lncRNA, enabling a
brand new cell-to-cell communication route (Valadi et al., 2007).
Hopefully, these coinciding revolutions will ultimately provide
fundamental breakthroughs and create radical new treatment
approaches to addiction disorders, benefiting the entire society.
We hope you will find this Special issue of Frontiers in Genetics
truly engaging and share our enthusiasm that we are living in
one of the most exciting time in scientific history, on a cusp of
a cosmic scale of discovery in biological sciences.
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